No abstract available
MeSH terms
-
Acute Disease
-
Antilymphocyte Serum / therapeutic use
-
Biopsy, Needle / economics
-
Cost-Benefit Analysis
-
Cyclosporine / therapeutic use
-
Graft Rejection / economics*
-
Graft Rejection / pathology
-
Graft Rejection / therapy
-
Humans
-
Hyperglycemia / chemically induced
-
Hyperglycemia / drug therapy
-
Hyperglycemia / epidemiology
-
Immunosuppression Therapy / economics*
-
Liver Transplantation / economics*
-
Liver Transplantation / immunology
-
Managed Care Programs / economics*
-
Methylprednisolone Hemisuccinate / adverse effects
-
Methylprednisolone Hemisuccinate / therapeutic use
-
Muromonab-CD3 / therapeutic use
-
Outpatients
-
United States
Substances
-
Antilymphocyte Serum
-
Muromonab-CD3
-
Methylprednisolone Hemisuccinate
-
Cyclosporine